| NDC Code | 64764-510-33 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64764-510-33) |
|---|
| Product NDC | 64764-510 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Actoplus Met |
|---|
| Proprietary Name Suffix | Xr |
|---|
| Non-Proprietary Name | Pioglitazone And Metformin Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20100611 |
|---|
| End Marketing Date | 20220930 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA022024 |
|---|
| Manufacturer | Takeda Pharmaceuticals America, Inc. |
|---|
| Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
|---|
| Strength | 1000; 15 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS] |
|---|